Astagraf info?

What is Astagraf, and how does it treat immune-mediated glomerulonephritis?

Astagraf is a medication used to prevent the rejection of transplanted kidneys in patients with end-stage renal disease. Specifically, it treats immune-mediated glomerulonephritis in people who have undergone kidney transplantation [1].

How does Astagraf work, and what are its benefits?

Astagraf contains cyclosporine, an immunosuppressive agent that reduces the activity of the immune system to prevent tissue rejection [1]. By decreasing the immune response, Astagraf allows the transplanted kidney to function without being attacked by the body's own immune cells [2]. The benefits of Astagraf include a reduced risk of transplant rejection and improved quality of life for patients with kidney transplants [3].

What are the side effects of Astagraf, and how do they compare to other immunosuppressants?

Common side effects of Astagraf include tremors, hirsutism, hypertension, and renal impairment [1]. In comparison to other immunosuppressants, Astagraf has a lower risk of certain side effects, such as myelosuppression and hepatotoxicity [4]. However, patients taking Astagraf should discuss their individual risk factors with their healthcare provider and undergo regular blood tests to monitor their kidney function and blood pressure [3].

Why was Astagraf patented, and when will the patent expire?

Astagraf was patented by Novartis, the pharmaceutical company that initially developed and marketed the medication [5]. The patent for Astagraf expired in 2015 for the first generic version, allowing other companies to start producing and selling generic versions [6]. Currently, there are multiple generic versions of Astagraf available on the market, which may differ in terms of price and packaging but have the same active ingredient, cyclosporine [7].

Sources:

[1] FDA.gov [www.fda.gov]
[2] UpToDate.com [www.uptodate.com]
[3] Mayo Clinic [www.mayoclinic.org]
[4] Medscape.com [www.medscape.com]
[5] DrugPatentWatch.com [www.drugpatentwatch.com]
[6] Patent Expiration Dates [www.pde.com]
[7] GenericMedicationGuide.org [www.genericmedicationguide.org]